Sandostatin LAR depot 30 MG KTS
Ended Awarded
- Contract number
- SPE2DB25FJC52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,301
Award facts
- Contract value 100% obligated
- $26,300.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,300.77 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price arrangement. This award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside delivery order. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Sandostatin LAR Depot, an octreotide formulation used for endocrine disorders and certain cancers, falls within the company's extensive portfolio of specialty medications. As a competitive prime contractor under DLA's pharmaceutical supply chain, AmerisourceBergen has demonstrated capability to meet federal medical supply requirements across diverse therapeutic domains, positioning it as a key supplier for Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJC52?
SPE2DB25FJC52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FJC52 worth?
The government has obligated $26,301 on SPE2DB25FJC52.
Is contract SPE2DB25FJC52 an order under another contract?
Yes. SPE2DB25FJC52 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJC52 competed?
The extent of competition for SPE2DB25FJC52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award